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Abstract
Genome-wide association studies (GWAS) have detected many disease associations. However, the reported variants tend to
explain small fractions of risk, and there are doubts about issues such as the portability of findings over different ethnic
groups or the relative roles of rare versus common variants in the genetic architecture of complex disease. Studying the
degree of sharing of disease-associated variants across populations can help in solving these issues. We present a
comprehensive survey of GWAS replicability across 28 diseases. Most loci and SNPs discovered in Europeans for these
conditions have been extensively replicated using peoples of European and East Asian ancestry, while the replication with
individuals of African ancestry is much less common. We found a strong and significant correlation of Odds Ratios across
Europeans and East Asians, indicating that underlying causal variants are common and shared between the two ancestries.
Moreover, SNPs that failed to replicate in East Asians map into genomic regions where Linkage Disequilibrium patterns
differ significantly between populations. Finally, we observed that GWAS with larger sample sizes have detected variants
with weaker effects rather than with lower frequencies. Our results indicate that most GWAS results are due to common
variants. In addition, the sharing of disease alleles and the high correlation in their effect sizes suggest that most of the
underlying causal variants are shared between Europeans and East Asians and that they tend to map close to the associated
marker SNPs.
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Introduction
Genome-wide association studies (GWAS) have detected
hundreds of risk alleles [1], generating novel biological knowledge
and widening the range of diagnostic and treatment tools [2].
However, the reported effect sizes of these variants are small and
their impact in individual risk prediction remains modest, raising
doubts about the relevance of GWAS results [1,3–6]. Some of the
most hotly debated topics are how to account for the unexplained
risk [4]; what may be the role of rare variants as a source of
synthetic GWAS results [7–10]; and up to what extent GWAS
results are portable between populations [11–15].
Answering to these questions is pressing for two reasons. First,
the description of the genetic architecture of disease lies at the
foundation of personalized medicine and, in particular, finding
predictors of individual disease risk that could be applicable to
different ancestries would be a major step forward [1] and would
also allow the development of prioritizing strategies to identify
disease-associated loci. Second, if sharing of causal variants across
populations were common, it would suggest trans-ethnic mapping
as a powered tool that would take profit of population
heterogeneity in LD and allele frequencies to identify the causal
variants underlying disease susceptibility [1,15].
The available reports on the allele frequency distribution of
GWAS risk variants point at an excess of common variants [16] that,
at least for some particular diseases [17], present consistent effects
across populations. If repeated, these observations constitute
empirical evidence against rare alleles as a source of synthetic
associations and would point at common variants that are in LD with
the associated tagSNPs in all populations. However, such studies
have not been generalized across different diseases and, currently,
most evidence accumulating in the field comes from either re-
sequencing efforts aimed to capture rare variants [18] or multi-ethnic
replication efforts for a few risk variants [13,15,17,19]. In addition,
most meta-analysis of GWAS data, that could shed light on these
issues, either have ignored population heterogeneity [2,20] or have
focused on a limited set of traits [21] and GWAS [22].
By compiling data from 299 GWAS for 28 different diseases, we
build a large database of discovery-and-replication patterns of SNPs
associated with complex disease. We evaluate the extent to which
risk variants discovered in Europeans replicate in posterior studies
performed on individuals of European, East Asian and African
ancestries and compare the risk effect sizes found across
populations. We also examine the extent up to which statistical
power and differences in Linkage Disequilibrium among popula-
tions explain replication failures. Our results describe the patterns
of replicability of GWAS across disease, evaluate how transport-
able these results are across populations and allow for inferences
about the relative roles of rare and common variants in explaining
current GWAS results.
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Results/Discussion
We started by downloading all the associations in the GWAS
Catalog [23] (last accessed in February 2012, see Materials and
Methods), which represents a total of 7,145 associations with
P,1025 reported in 1,171 papers. To study trans-ethnic
replicability across diseases, we first focused on GWAS performed
upon the two most studied ancestral groups: Europeans and East
Asians. We avoided quantitative traits, such as height or BMI,
because they could be subject to different evolutionary pressures
than disease traits and, thus, may present different replicability
patterns. We selected for analysis diseases for which GWAS had
been performed several times. In particular, we required (i) two
or more GWAS with peoples of the same ancestry group; and (ii)
at least one GWAS with subjects from the other ancestry group.
A total of 28 diseases and 277 GWAS (206 European and 71 East
Asian) fulfilled our criteria (average ,10 papers per disease,
range = 3–27 papers; see Materials and Methods and Tables S1
and S2). We further performed an exhaustive search of the
literature to detect any GWAS published before February 2012
but not available in the Catalog (see Materials and Methods).
This effort yielded six new GWAS that we included in our
database (Table S3 and Table S2, in yellow). Finally, and to be as
comprehensive as possible, we included 16 GWAS performed on
peoples of African American ancestry that were available for
eight of the previously ascertained 28 diseases. This rendered a
final dataset of 299 GWAS papers reporting 419 associations to
28 diseases (Table S2). Out of these, we ascertained 190 SNPs
initially reported as genome-wide significant (P,561027, or
P,561028 if the study included imputed SNPs) in European
GWAS and for which one or more replication attempts had been
performed in subsequent European, East Asian and/or African
GWAS (181, 225 and 61 attempts, respectively, Tables S4 and
S5). We studied patterns of replication across studies, using the
criterion that a replication was successful if the same risk allele
achieved P,0.05. To obtain that information we examined every
individual paper, since the GWAS Catalog records only P,1025
(see Materials and Methods for a detailed description of the
filtering process). Our database is available at http://
biologiaevolutiva.org/anavarro/software-data/.
Replicability rates and sharing across Europeans and East
Asians
Replicability rates are high within Europeans, with 155
successful out of 181 attempts (85.6%), when only 9 positive
replications (,5%) would be expected under the null hypothesis of
no association (binomial test, P,10216). This excess was robust to
the significance threshold (e.g. 122 observed vs. 0.18 expected if
only replication attempts achieving P,0.001 are considered
successful and 56 observed vs. 1.861025 expected for a threshold
of P,1027, Table S5). Moreover, replicability rates within
Europeans approach 100% when accounting for statistical power.
For the 168 attempts for which we could calculate the power to
replicate the original finding (Table S5), we observed 147 positive
replications, which is almost identical to the expectation of 149.1
positive replications given that average power is 89.1% (see
Materials and Methods). This is expected, since most GWAS
already contain an internal replication phase [1,24]. Interestingly,
all diseases presented similarly high replicability patterns, with no
traces of heterogeneity in replicability (Table S6). These results
were consistent with previous partial reports of replication for
individual diseases [17,19] and confirmed that the subset of 190
genome-wide significant SNPs map in loci truly associated with
disease in peoples of European ancestry.
Next, we considered the replication attempts in East Asian
populations. Out of 225 replication attempts, 103 were successful
at a P,0.05 threshold (45.8%). This replicability departs
significantly from the null expectation (103 vs. 11.3 expected,
P,10216) and is robust across replication thresholds (e.g. 49
observed vs. 0.23 expected for P,0.001 and 19 observed vs.
2.361025 expected for P,1027). Nevertheless, that figure is
smaller than for Europeans, which can be expected since East
Asian GWAS tend to have smaller sample sizes and, thus, less
power [15]. We tested this hypothesis by calculating replicability
rates after controlling for statistical power. First, we focused on the
81 attempts with $80% power to replicate the Odds Ratio (OR)
found in Europeans (Table S5 and Materials and Methods). For
that subset, replicability increases dramatically to 76.5% (62 out of
81 attempts are successful with a P,0.05 threshold). Second, we
calculated that at most 132 positive replications would be expected
out of statistical power (59% on average for the 225 attempts in
East Asians, Table S5). The 103 observed replications thus
correspond to an effective replicability rate of 77.9%, which
suggests that a noticeable fraction of GWAS associations are
shared across Eurasians. Again, we found no heterogeneity across
diseases (Table S7).
Finally, we considered replication attempts performed upon
individuals of African ancestry. Even if GWAS on individuals of
non-Eurasian ancestry are scarce, we could find 16 GWAS
performed on African Americans from which we gathered a total
of 73 replication attempts (61 and 12 for SNPs discovered in
Europeans and East Asians, respectively; see Materials and
Methods and Table S1). Overall, we observed a low replicability
rate (9.6%, 7 out of 73 attempts) that was not attributable to lack
of statistical power (59.2% on average, see Table S5). This figure
would cast doubts about the sharing of causal variants between
Eurasians and Africans, but the inherent limitations of this part of
the analysis warrant for caution. For instance, lower levels of LD in
Africans than in Eurasians make it difficult to ensure that
potentially shared causal variants are tagged by the same marker
SNP [25]. Additionally, the 16 African-American GWAS form a
rather small dataset corresponding to only five diseases (asthma,
cardiovascular disease, hypertension, prostate cancer and type 2
Author Summary
Describing and identifying the genetic variants that
increase risk for complex diseases remains a central focus
of human genetics and is fundamental for the emergent
field of personalized medicine. Over the last six years,
GWAS have revolutionized the field, discovering hundreds
of disease loci. However, with only a handful of exceptions,
the causal variants that generate the associations unveiled
by GWAS have not been identified, and their frequency
and degree of sharing across populations remains
unknown. Here, we present a comprehensive comparison
of GWAS results designed to try to understand the nature
of causal variants. By examining the results of GWAS for 28
diseases that have been performed with peoples of
European, East Asian, and African ancestries, we conclude
that a large fraction of associations are caused by common
causal variants that should map relatively close to the
associated markers. Our results indicate that many of the
disease risk variants discovered by GWAS are shared across
Eurasians.
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diabetes). A complete study of African replicabilities will be
possible when more studies are available. In the meantime, we
focused on data gathered from European and East Asian GWAS.
Odds Ratios for Europeans and East Asians are strongly
correlated
The observed rates of trans-ethnic replication between Euro-
peans and East Asians indicate that a considerable fraction of risk
loci associated with the 28 diseases is shared between the two
Continental groups. As to the sharing and frequency of risk
variants, it can be explored even if the causal variants themselves
remain undiscovered. First, the possibility that the same causal
variants underlie association in the two continents is reinforced by
the strong correlation between the ORs for SNPs discovered in
European GWAS and their replication OR in the largest East
Asian study (Spearman’s r= 0.82, P,10216, Figure 1; we used the
log(OR) to ensure symmetry around 1). Also, the slope of the
linear regression of the two log(OR) is very close to 1 (1.03,
SE = 0.064, P,10216), which indicates that the log(OR) found in
Europeans is the best predictor of the East Asian log(OR). These
figures would be unexpected if GWAS hits were synthetically
generated by population-specific rare causal variants, as their
effect size and Linkage Disequilibrium (LD) with the replicated
SNP would be different in each population. Moreover, when
considering only replication attempts that did not achieve P,0.05
in East Asians, there is still a strong and significant correlation
between the two ancestries’ OR (Spearman’s r= 0.53, P,2?1029),
which suggests that a fraction of these associations might also be
shared even if not successfully replicated in East Asians. A final
further piece of evidence indicates that causal alleles behind non-
replicated SNPs might actually be common and shared. Since
most rare variants occurred after the split of Europeans and East
Asians [4,12,26–28], they would have accumulated randomly in
the genealogy of each allele of the tagSNP used in GWAS.
Therefore, if causal variants were rare, risk alleles would not be
necessarily shared even if discovered through the same tagSNP.
Strikingly, when considering the direction of effects of SNPs non-
replicated in East Asians instead of only their significance, the
same risk allele as in Europeans was observed for 73.6% of
attempts. This proportion clearly departs from the 50% expecta-
tion in a scenario of independent sets of rare variants generating
different synthetic associations if each continent (P,10216,
binomial test).
Assessing the potential effect of publication bias
Publication bias could have inflated our replicability estimates
[29,30]. Due to the large number of SNPs that are tested, the usual
practice when publishing a GWAS has been to report all newly
discovered associations, plus the replication status of previously
associated SNPs. However, this is not always the case and, in some
cases, not all previous results are discussed in each publication.
Therefore, our ability to gather replication attempts depends on
how many of them are explicitly reported, which presents
enormous variability among papers. This opens the possibility of
a reporting bias, in which GWAS authors could prioritize
mentioning successful replication attempts, while overlooking
failed replications. If so, our chance of gathering a replication
attempt might be heavily biased towards positive results, thus
inflating our estimates of replicability [30].
In the most extreme version of this scenario, the 103 observed
replications in East Asians at P,0.05 that find the same risk allele
that had been previously discovered in European studies would be
the result of type I error with a P = 0.05 threshold. In that case, the
103 positive replications would be just the 2.5% ( = 5% type I
error650% probability of the same risk allele) of a large pool of
4,120 replication attempts in East Asians (95% C.I. = 3,418–4,959,
assuming a Poisson distribution). In other words, 4,017
( = 4,1202103) associations failing to find the same risk allele at
Figure 1. East Asian GWAS find the same risk allele and similar log(OR) than European discovery GWAS. X axis: log(OR) for the
replication stage of the discovery European GWAS. Y axis: log(OR) for the initial stage of East Asian GWAS (Materials and Methods). Dots in blue
indicate significant (P,0.05) replication attempts in East Asia; dots in grey indicate non-significant replication attempts. (A) Using all replication
attempts; (B) Using only the most-powered replication attempt per SNP; (C) Using the most-powered replication attempt per region. Attempts
correspondent to SNPs with MAF,0.01 in East Asians are not shown.
doi:10.1371/journal.pgen.1003566.g001
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P,0.05 would have remained unreported. Given the huge
amount of unpublished GWAS that this scenario would imply,
we discard a big impact of publication bias in our analysis.
To obtain a more precise assessment of the potential size of
reporting bias in East Asian GWAS, we estimated the maximum
number of failed (P.0.05) but unreported replication attempts
that is actually possible in our database [30]. Specifically, and for
each East Asian GWAS, we computed the number of disease-
associated SNPs discovered in Europeans that were not mentioned
in East Asian studies (neither a p-value nor any other information
was reported in the main text or in the supplemental information).
In total, we found 416 such instances. Most of these cases may not
constitute reporting bias at all, since the SNPs in question may not
be included in the array used for the East Asian GWAS, may be
monomorphic in the studied population, may have been filtered
out during QC and so on. Still, making the extreme assumption
that all these 416 cases are failed replications, they constitute the
maximum number of biased reports that we could have not
included in our database (Table S8). Under this extreme scenario,
the 103 positive replications would not have been drawn from the
225 replication attempts gathered in our database, but from a
larger set of 641 ( = 225+416) replication attempts in East Asians.
This calculation allows us to estimate the lower-bound replicability
rate at 16.1% (103 out of 641), which still departs from the null
expectation of 5% (P = 10216; Binomial test). In other words, the
figure of 416 ungathered replication attempts is about an order of
magnitude lower than the total number of unreported cases
needed to explain all East Asian replications as type I errors
(4,017, see previous paragraph) and, therefore, it is very unlikely
that systematic reporting bias accounts for our results.
Replicability and differences in Linkage Disequilibrium
and Heterozygosity
A clear prediction can be made if, as our results suggest, a
substantial fraction of associations reported by European GWAS
are caused by common variants with similar effect sizes across the
two ancestral groups: whenever associations were successfully
replicated, the frequencies of tagSNPs and causal variants and
their LD relationships should be similar in the two groups. In other
words, levels of heterozygosity and LD patterns should be more
similar between populations in the genomic regions that contain
successfully replicated SNPs than in the genomic regions with
European-associated SNPs that have not reached significance in
East Asians. To test this prediction, we compared the inter-
continental similitude of heterozygosity and LD in genomic
regions harboring two different groups of disease-associated SNPs:
the 47 SNPs discovered in Europeans that have been successfully
replicated in every attempt with East Asians and the 65 SNPs that
have never been positively replicated.
We compared heterozygosity patterns by measuring the
differences in average heterozygosity between Europeans and
East Asians. We measured these differences between the two
ancestry groups in a 600-SNP region around each SNP under
study. We used sliding windows of 50 consecutive SNPs, with a
step of 5 SNPs. As predicted, windows immediately centered on
non-replicated SNPs presented significantly larger differences in
average heterozygosity across populations than windows centered
on replicated SNPs (0.048 vs. 0.019, P,0.009, Figure 2).
Analogous patterns were observed when comparing the
differences in LD. To assess differences in LD between popula-
tions, we computed the varLD score [31] in the same 50-SNP
sliding windows we used for heterozygosity. As predicted,
differences in LD were significantly larger for the windows
centered in non-replicated than in replicated SNPs (varLD = 17.64
vs. 12.66, P,0.002). Indeed, varLD differences are only significant
in the immediate vicinity of the associated SNP and they quickly
cancel out as the distance for the associated allele increases
(Figure 3 and Table S9). We obtained the same result when using
only attempts with $80% statistical power and contrasting 39
replicated versus 14 non-replicated SNPs (varLD = 20.42 vs.
12.49, P = 0.045).
To study how differences in LD patterns compare with the
genome-wide average, we focused on the region immediately
adjacent to the marker SNPs. For a window of 50 SNPs around
the marker, we compared differences between Europeans and East
Asians in LD patterns around replicated and non-replicated SNPs
to genome-wide average differences for random SNPs. We used
the permutation method included in varLD to assign an empirical
p-value to the observed differences in LD for each analyzed
window (see Materials and Methods). We considered three
different sets of 50-SNP windows centered on each of the (i) 47
replicated SNPs, (ii) 64 non-replicated SNPs, and (iii) 100 groups
of 47 SNPs randomly selected from across the genome. Because
the two populations differ in their LD patterns, we observed a
trend towards significant differences in LD (empirical P,0.05) for
the three datasets. However, the proportion of significant windows
was larger for non-replicated (78%) than for replicated (62%) and
random genomic SNPs (66%). Figure 4 shows the cumulative
distributions of empirical p-values for the three groups of SNPs.
The cumulative distribution of p-values correspondent to repli-
cated SNPs does not depart from genome-wide expectations, while
non-replicated SNPs clearly map into regions of the genome with
extreme differences in LD between Europeans and East Asians. In
other words: our observations on LD differences suggest that a
proportion of associations would have failed to replicate in East
Asians because of population heterogeneity in LD between causal
variants and tagSNPs. Yet, the possibilities of heterogeneity across
populations in the effect size of causal variants themselves (see
[22,32]) or the presence of European-specific causal rare variants
in some associations cannot be discarded as a source of lack of
replication.
Comparison with previous results
Our results indicate that many causal variants underlying
GWAS results are common and shared between Europeans and
East Asians, extending the observation of reports that focused in
single traits [17,19]. This would seem to contradict results by us
and others that highlighted heterogeneity in the genetic etiology of
disease across human populations [14,21,22]. This observation
contrasts with the large replicability and large correlation in OR
that we observe, as well as with the suggested role of differences in
LD in explaining associations non-replicated in East Asians. The
apparent contradiction between the present and previous papers
can be explained by two facts. First, our previous results focused
on candidate-gene studies, which have been largely dominated by
false positives [14]; and, second, studies that considered GWAS
data addressed different questions, used different approaches and
gathered different sets of traits [21] and/or associations [22].
An examination of previous datasets confirms a general trend to
consistency of GWAS results across continents and emphasizes the
benefits of incorporating as many associations as possible. Fu et al.
[21] focused on associated SNPs discovered in East Asian GWAS.
Although they used only four traits and 47 SNPs (43 loci), they
demonstrated the challenges of multi-ethnic studies, and provided
a framework to cope with these difficulties. As discussed by the
authors, caution is warranted as to whether the disease loci and/or
causal variants are population-specific. For instance, they suggest-
ed that two signals for type 2 diabetes located in 9p24.1 (PTPRD,
GWAS Variants Are Common and Shared across Eurasia
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rs17584499) and 17p13.3 (SRR, rs391300) could be East Asian-
specific, as they fail to replicate in a well-powered study in
Europeans. However, we gathered several replication attempts of
these two signals in more recent East Asian GWAS (Table S4), and
out of 8 replication attempts only one was successful (for PTPRD,
rs17584499) at P,0.05, when a total of 7.49 replications would be
expected by power alone (4 for PTPRD and 3.49 for SRR, see
Table S5). Also, in only 4 out of 8 cases the risk allele was the same
(two for each gene). Overall, the replication attempts gathered in
our database suggest that both associations were false positive
findings in East Asians. These results make it clear that Fu et al.
[21] were right in asking for caution, since putative population-
specific associations may well turn out to be false positives.
Moreover, the inclusion of more recent studies in our dataset helps
discarding the population-specific status of some true associations.
For instance, the association of 10p13 (CAMK1D, rs12779790) to
type 2 diabetes was considered as European-specific, but it has
been eventually replicated in East Asians [33].
Ntzani et al. [22] examined differences in effect sizes from a set
of 108 associations discovered by GWAS and for which data for
various ancestries was available. Because of the sophistication of
their approach, they had to focus on 12 diseases and 4
anthropometric traits, as well as on a relatively short (,30) list
of GWAS that either use samples with different ancestries in the
replication stage or compare their own results with previous papers
using different ancestries [22]. In contrast, we took the simpler
approach of studying replicability in the studies with largest sample
size, so we could gather attempts from multiple GWAS on the
same diseases and were able to construct a larger database. Ntzani
et al. [22] found overall consistency in effect direction across
ancestries (,82%, similar to ours of 85%), but with modest
correlations in effect sizes, (rho<0.33) that would seem
Figure 2. Difference in Average Heterozygosity between Europeans and East Asians. The x axis represents the distance of each 50-SNP
window from the associated SNPs. The y axis shows the average heterozygosity for Europeans minus that of East Asians (SEM indicated in shadow).
The band in bisque indicates the windows with significant differences (P,0.01).
doi:10.1371/journal.pgen.1003566.g002
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contradictory with the large correlation in odds ratios we report
here. Nevertheless, an almost identical correlation in OR would
have been observed if limiting the study to the 22 SNPs that are
shared between Ntzani et al. [22] and our dataset (rho = 0.58 and
0.53, respectively). Barring possible differences due to the different
nature of the anthropometric traits analyzed by Ntzani et al. [22],
the previous results stress the importance of continuously updating
the list of replication attempts to increase the statistical power
upon which inferences can be based.
Effective replicability rates of larger GWAS hints at
weaker but common causal variants
Of course, the finding of shared variants underlying GWAS
results holds only for associations that have been published so far.
Ongoing efforts to join cohorts into large consortia [34] ensure
steady progress in the field and guarantee the discovery of new
genetic associations to complex disease [6,35]. It is tempting to
make inferences about what may be the results of future, much
larger, association studies; particularly about the frequency and
degree of trans-ethnic sharing of as yet undiscovered variants. We
approximated this question by considering the allele frequencies
and effect sizes of associated SNPs along with their patterns of
replicability across time. Specifically, it is clear that if the GWAS
with larger sample sizes that have been published recently for
peoples of European ancestry had discovered variants with lower
frequencies (variants that should be increasingly population-
specific), their results should be less likely to replicate across
populations. If this observation were made, it would predict
decreased replicabilities in future, even larger GWAS with
increased power to discover lower-frequency risk variants.
As observed in Figure 5, more recent GWAS have gathered
larger sample sizes and unveiled associations with lower ORs.
Figure 3. Regions harboring non-replicated SNPs present larger differences in LD between Europeans and East Asians. Measures of
difference in LD (varLD scores) are given for sliding windows of 50 SNPs with a 5-SNP step. Measures for replicated and non-replicated SNPs are given
as blue and black lines, respectively. Shadowed areas represent the standard error of the mean. The vertical red band indicates that all windows with
significant differences (P,0.01) locate in the vicinity of the associated SNPs.
doi:10.1371/journal.pgen.1003566.g003
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Although more recent GWAS present decreased replicability rates,
an interesting inference can be made by observing effective
replicability rates, the ratio between the proportion of positive
replications and their statistical power. Effective replicability
would be expected to decrease if the lower ORs detected by
GWAS were due to lower-frequency (and thus increasingly
population-specific) causal variants. In contrast, we observed a
constant effective replicability rate of ,80% that was independent
of the OR reported in the European discovery GWAS (red line in
Figure 5), indicating that the associations discovered by larger
GWAS present similarly high replicability rates regardless of their
weaker effect size.
Changing focus to minor allele frequencies, it is possible that,
regardless of the reported OR, genotyped marker SNPs with lower
MAFs are more efficient in tagging low frequency causal variants.
If that were the case, patterns of replicability may change as a
function of the MAF of associated SNPs. Nevertheless, we
observed similar rates of effective replicability across all the
frequency spectrum of disease-associated SNPs, with no drastic
decrease for markers of increasingly smaller MAFs (Figure 6).
All these inferences are confirmed after categorizing European
discovery GWAS into two groups using a threshold of 10,000
individuals to distinguish between ‘‘small’’ and ‘‘large’’ studies.
First, we did not observe differences in the MAF distribution of
associated SNPs according to the discovery sample size (average
MAF of 0.301 vs. 0.333 for ‘‘small’’ and ‘‘large’’ GWAS
respectively; P = 0.12, Wilcoxon test). Second, even if larger
GWAS do indeed detect associations with smaller ORs (average
OR 1.15 vs. 1.28; P,361027), the trans-continental correlation of
ORs between Europeans and East Asians was the same for
Figure 4. Regions with non-replicated SNPs depart from the genome-wide expectation of regional differences in LD patterns
between Europeans and East Asians. The cumulative distributions of varLD targeted P-values after 1,000 permutations for non-replicated SNPs
(n = 64, in gray) and replicated SNPs (n = 47, in blue) are shown. The median (black dashed line) and 95% empirical CI (green area) calculated for 100
groups of 47 SNPs randomly selected from across the genome are also depicted.
doi:10.1371/journal.pgen.1003566.g004
GWAS Variants Are Common and Shared across Eurasia
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‘‘small’’ and ‘‘large’’ GWAS (Figure 7). Both results show, yet
again, that causal variants of different effect sizes are equally
shared across populations, independently of the sample size of the
discovery GWAS.
Building a database of replication attempts from non-
GWAS studies
GWAS focus on describing new variants across the genome
rather than validating the findings from previous GWAS. Instead,
many replication attempts consist on genotyping limited sets of
SNPs previously discovered by GWAS in independent samples.
They tend to be published independently from GWAS and, hence,
our replicability database may have failed to gather many
replication attempts that occur outside the setting of genome-
wide studies. Since endeavoring to analyze all the literature
available for the 28 diseases in our database would have required a
massive effort, we randomly selected six diseases to address this
possibility (Table S10). For each disease, we searched all the
publications citing each of the disease-associated variants present
in our database, as well as for the original GWAS publications
initially describing them.
In total, we looked at 1,706 and 6,068 citations available at
PubMed and Google Scholar by December 2012, respectively
(Table S10). In doing so, we gathered a total of 59 replication
attempts from 38 candidate studies targeting GWAS variants
discovered in Europeans (40 and 19 attempts used individuals of
European and East Asian ancestry, respectively, see Table S11).
Nonetheless, the observed effective replicability rates after
accounting for statistical power of attempts gathered from GWAS
and non-GWAS studies are very similar in both Europeans and
East Asians (93.8% vs. 89.5%; P = 0.20 and 80.6% vs. 88.4%,
P = 0.69; respectively). Thus, the inclusion of replication attempts
Figure 5. Replicabilities against ORs in the discovery study. For every SNP discovered in Europeans, all the replication attempts in East Asians
were considered and classified by bins of OR found in Europeans. The OR of SNPs with risk alleles being major was transformed to ensure OR.1. By
means of windows with step 0.3, the average statistical power (empty black circles), average replication success (solid black circles) and effective
replicability (the ratio between observed and expected replicability, the two former quantities, red circles) are shown (using only windows with $20
attempts). Top values of the graph represent the average date of publication and sample size of discovery GWAS, for bins of 0.1 OR.
doi:10.1371/journal.pgen.1003566.g005
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that occur outside from the setting of GWAS should not have
affected the patterns of replicability we report in the present study.
Conclusions
The relevance of our findings is that they allow for three
inferences. First, they contribute to the debate on the possible
synthetic origin of GWAS associations [7,8,10], since trans-
continental replicability confirms that most –even if not all– of
the associations detected by GWAS are not caused by popula-
tion-specific, rare variants. Second, they clarify the contribution
of common variants to extant GWAS results, since practically all
GWAS have delivered precisely what they were designed to
detect: associations with common variants [1]. Third, our results
show that a substantial proportion of causal variants are shared
across European and East Asian populations and that they
probably lie in the regions close to marker SNPs, which may
allow leveraging on the increasingly varied ancestries of GWAS
to track them down [25,36–38]. Finally, since larger GWAS did
not detect variants with lower frequencies, our findings support a
model of common variants of varying effect sizes, closer to the
infinitesimal model than to a pure rare variant model of the
genetic architecture of disease [4]. However, it is not simple to
extrapolate our results to associations that so far remain
undiscovered. Whether the heritability that is not yet explained
by GWAS will be partly due to risk variants in insufficient LD
with common SNP markers, as suggested by some authors [6,39]
or whether this heritability exists at all [40] will only be resolved
by further empirical research.
Figure 6. Replicabilities against MAFs in the discovery study. For every SNP discovered in Europeans, all the replication attempts in East
Asians were considered and classified by bins of OR found in Europeans. By means of windows with step 0.3, the average statistical power (empty
black circles), average replication success (solid black circles) and effective replicability (the ratio between observed and expected replicability, the
two former quantities, red circles) are shown (using only windows with $20 attempts). Top values of the graph represent the average date of
publication and sample size of discovery GWAS, for each bin of MAF.
doi:10.1371/journal.pgen.1003566.g006
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Materials and Methods
Creating a database of SNPs associated with disease
We considered the 1,171 studies indexed in the catalog of
Published Genome-Wide Association Studies as to February 2012
(http://www.genome.gov/26525384, last accessed 14th February
2012) and classified them according to the trait under study. Each
study was classified according to the genetic ancestry of the
samples, considering only individuals used in the GWAS stage.
Studies performed on a mixed panel were considered only if
separate ancestry-specific analyses were provided and we recorded
them as independent studies. We observed a strong bias towards
GWAS performed with ‘‘European’’ (78.4%) and ‘‘East Asian’’
(14.9%) individuals, while much fewer studies are available for
‘‘African’’ (4.3%), ‘‘Hispanic’’ (1.2%), ‘‘Middle Eastern’’ (0.5%),
‘‘Native American’’ (0.4%) and ‘‘Oceanian’’ (0.3%) ancestries.
Therefore, and to increase the reliability of our results, we focused
on GWAS performed with peoples of European and East Asian
ancestry to select frequently studied diseases. We ascertained only
dichotomous disease traits, avoiding anthropometric traits such as
height. To produce reliable replicability estimates across ancestries
we included in our analysis the 28 diseases for which two or more
GWAS were available in any of the two ancestral groups and at
least one in the other group (e.g. 11 GWAS for lung cancer in
Europeans and 5 in East Asians; 4 GWAS for Kawasaki Disease, 1
in Europeans and 3 in East Asians). Finally, we also added GWAS
performed upon individuals of African ancestry for any of the 28
selected diseases.
We built a database with 28 dichotomous disease phenotypes
(Table S1), with data coming from 206 European, 71 East Asian
and 16 African GWAS. Several features of interest were recorded
for each GWAS: first author, journal, year of publication, genetic
ancestry, sample size in GWAS stage, total sample size in
replication stage, array genotyped, genomic control factor in
Figure 7. Similar correlation between European and East Asian log(OR), regardless of the discovery GWAS sample size. This figure is
a redraw of the points shown in Figure 1A but colored according to the discovery GWAS sample size. The same correlations arose when using all
replication attempts (as it is shown in Figure) or the filtered (n = 123) set of largest replication attempt per SNP (not shown).
doi:10.1371/journal.pgen.1003566.g007
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GWAS stage (if available), use of imputed SNPs (Y/N) and
number of genomic regions achieving genome-wide significance in
the initial and final stage (Table S2). The publications corre-
sponding to each GWAS were downloaded from the respective
journals.
To explore the full range of published GWAS, we performed a
comprehensive independent search for studies not gathered in the
Catalog. For each of the 28 diseases, we mined three resources: (i)
the PubMed database of biomedical literature, (ii) the HuGE
Navigator tool available at the Human Genome Epidemiology
Network [41] and (iii) specific reviews available in the literature.
Specifically, we searched the PubMed to identify potential new
GWAS (i.e. ‘‘Asthma AND genome-wide’’) and the ‘‘HuGE
Literature Finder’’ available at the HuGE Navigator. Finally, we
used the PubMed (‘‘Review’’ tool in Article types) to identify 59
reviews covering the literature available for each disease (,2.4
reviews per disease). After examination of all these sources, we
complemented the list of 277 GWAS with six new genome-wide
studies performed on Europeans that had remained unnoticed in
the Catalog (Tables S2 and S3).
For each disease, the selected studies were sorted per date of
publication regardless of the population of study. Starting for the
first study, we built a cumulative database of disease-associated
SNPs and their replicability in successive studies. After excluding
GWAS with pooled DNAs or focusing on CNVs, each GWAS
publication was visually screened for two kinds of association data:
the report of a new disease-associated SNPs (discovered SNPs);
and the replication status of disease-associated SNPs discovered in
previous GWAS (replicated SNPs). In both cases, we recorded
three features from each association: (i) Odds Ratio (OR) (ii)
confidence interval of the OR and (iii) the p-value.
We used several conservative criteria to include newly
discovered SNPs in our database. First, to avoid the winner’s
curse bias, we used the OR and p-value from the replication stages
of the discovery GWAS. Second, when several replication stages
from the same GWAS were available, the OR from the stage with
largest sample size was recorded. Only when no replication stages
were available did we use the OR from the GWAS stage. Third,
SNPs associated uniquely in sex-specific analyses were excluded.
Fourth, ORs coming from allelic tests and additive models were
prioritized over genotypic tests and other genetic models. Fifth, the
genome-wide significance level for a newly discovered SNP to be
included in our analysis was set at P,561027, unless imputed
SNPs were used in the GWAS, in which we toughened up the
threshold to P,561028. Sixth, for genomic regions with several
genome-wide significant SNPs (SNPs less than 200 Kb from each
other), we included in the study the SNP with lowest p-value.
Finally, disease-associated SNPs from the MHC region and HLA
alleles were not included in the study. In several analyses, we used
the log(OR) to ensure symmetry, which does not happen if using
OR (i.e. an OR of 2 is equivalent to an OR of 0.5).
For replication attempts to be included in our database, several
conservative conditions had to be met. We only recorded attempts
in which exactly the same SNP than in the discovery GWAS had
been genotyped. Moreover, and to avoid any bias towards
associations that replicate across ancestries, we did not gather
any replication attempt from the same ‘‘discovery’’ GWAS in
which a new disease-associated SNP is described. Third, in all
these cases, the p-value considered for the replication report was
the one from the GWAS stage. Finally, the OR for each disease-
associated SNP was referenced for the allele that had been the risk
allele in the discovery study. Thus, OR,1 (and log(OR),0)
means that the minor allele was found as protective in the
discovery study, while OR.1 (and log(OR).0) means that the
minor allele appeared as the risk allele. For SNPs with different
minor alleles across populations, OR were referenced to the minor
allele specific for each population. Instances of the latter are
indicated in column ‘‘Shift’’ in Table S5 and the shifted OR is
represented in all Figures except when otherwise indicated.
A total of 419 discovered SNPs from 337 genomic regions were
found to be associated with disease, 320 of those SNPs being
reported for the first time in Europeans, 97 in East Asians and 2 in
Africans (Table S4). In total, we gathered 543 replication reports,
dealing with 227 out of the 419 discovered SNPs (Table S5). Out
of the 543 replication reports, 210, 260 and 73 corresponded,
respectively, to attempts performed on Europeans, East Asians and
on Africans. Since East Asian and African GWAS are more recent,
most of the replication attempts (465 out of 536, 87%) reported the
replication status of discovered SNPs that had been reported for
the first time in Europeans. Therefore, we focused on the subset of
465 replication attempts gathered for 190 associated SNPs
discovered in European GWAS. Out of these, a total of 181,
225 and 61 replication attempts had been reported for Europeans,
East Asians and Africans, respectively.
The 225 replication attempts in East Asians aimed to replicate a
total of 131 SNPs associated with disease with genome-wide
significance in Europeans, which results in an average of 1.75
replication attempts per associated SNP (range = 1–7). Thus, our
estimates of replicability could be biased if replicated SNPs
gathered more replication attempts per SNP, or more associated
SNPs in European populations. During the analysis, and as noted
in the text, we applied an additive filtering to ensure no bias in the
estimates of replicability and correlations between European and
East Asian OR. Specifically, we repeated the analysis selecting
only the largest replication attempt per SNP, resulting in a filtered
set of 123 attempts. The SNPs ascertained for the filtering are
indicated in Table S5.
Population genetics analysis (varLD and Heterozygosity)
Polymorphism data was downloaded from HapMap Project
Phase 2 (release 24, November 2008). For each ascertained SNP,
we downloaded two data sets: (i) genotypes for the associated SNP
and (ii) genotypes for a 600-SNP window centered on the
associated SNP. We downloaded all genotypes for all unrelated
samples from the three populations of European and East Asian
ancestry (CEU, JPT and CHB). JPT and CHB samples were
clustered together due to their close genetic relationship.
Population differences in local patterns of Linkage Disequilib-
rium (LD) around disease associated SNPs were measured with the
varLD software (www.nus-cme.org.sg/software/varld.html) [3],
using the targeted option for 50-SNP windows. For each population
and genomic region, varLD builds a matrix of pairwise signed r2
values among all the SNP pairs and provides a raw score
corresponding to the absolute difference in the eigen-decomposi-
tions between two matrices. This score is a summary measure of
the overall LD levels in a given genomic region between two
populations. We used it to measure the extent of differences in
local LD between two kind of genomic regions: these containing
replicated and non-replicated SNPs. To rule out the possibility
that differences in LD between replicated and non-replicated
SNPs are not related to the presence of the disease associated SNP,
we scanned varLD differences in consecutive windows of the same
size (50 SNP), starting 300 SNPs upstream of the disease associated
SNP and finishing 300 SNPs downstream, with an step of 5 SNPs.
In total, we checked 121 consecutive windows around the disease
associated SNP. On average, we were examining a window of
503.61 Kb centered on each associated SNP.
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We used a similar sliding window approach to summarize the
differences in allele frequencies between Europeans and East
Asians. Again, we did it for each SNP, calculating the average
heterozygosity in each window for replicated and non-replicated
SNPs. Differences in heterozygosity are simply the result of
subtracting the average heterozygosity in East Asians from that in
Europeans (Figure 2).
To compare LD differences of associated SNPs to the genome-
wide background, we used the varLD targeted option that tests the
null hypothesis that the correlations in LD between SNPs from a
given window are equal in both populations. We implemented
1,000 permutations to calculate the empirical p-value for each 50-
SNP window. Then, we built three cumulative distributions
correspondent to each of the three sets of SNPs: replicated (n = 47),
non-replicated (n = 64) and random genomic (n = 4,700) SNPs.
The SNPs selected for the latter dataset were ascertained from
HapMap Phase 2 in order to randomly match the minor allele
frequencies of replicated and non-replicated SNPs in Europeans.
Finally, we randomly created 100 groups of 47 genomic SNPs to
calculate the median and 95% empirical CI of permutation
p-values available at Figure 4.
Power and statistical analyses
As noted in the text, for some analysis we focused on the
attempts that had.80% power to replicate the effect size found in
Europeans. Statistical Power was calculated with the CaTS Power
Calculator (www.sph.umich.edu/csg/abecasis/CaTS/) [42]. For
each replication attempt we checked the power under a log-
additive model to find the same effect size as in the discovery
European GWAS, given the sample size of the replication GWAS
and the allele frequency of the risk allele in East Asians. The
number of expected replications was approached by multiplying
the total number of replication attempts with the statistical power
to replicate averaged for all attempts (see Table S5)
Statistical analyses were performed using standard R proce-
dures. The significance of the replicability estimates was checked
by means of a binomial test, with an expected replicability rate of
0.05 under the null hypothesis of no shared associated SNPs
between Europeans and East Asians or Europeans and Africans.
Similarly, the significance in the risk allele direction was checked
by means of a binomial test, using a null expected ratio of 0.5. As
indicated in the first section, differences in LD between replicated
and non-replicated SNPs were checked by means of Mann-
Whitney tests comparing the distributions of varLD scores for
sliding 50-SNP windows centered on the disease-associated SNPs.
The same procedure was used for the average difference in
heterozygosity and distributions of OR found by ‘‘small’’ and
‘‘large’’ GWAS.
Supporting Information
Table S1 List of ascertained diseases. A comprehensive list of all
diseases considered is available, along with the reason for exclusion
if not present in the list of 28 ascertained diseases. The number of
GWAS available for each of the three ancestries is also provided.
(XLSX)
Table S2 Main features of the GWAS ascertained for the
present study. The main features of the 299 analyzed GWAS is
provided. The six GWAS not present in the Catalog and selected
after a literature survey are marked in yellow (Table S3).
(XLSX)
Table S3 Survey of the literature and reviews looking for GWAS
not gathered in the Catalog. For each disease, the HuGE
Navigator and several available reviews were screened to look
for GWAS not available in the Catalog. The title, PubMed ID,
year of publication along with a comment about all considered
non-Catalog GWAS is provided.
(XLSX)
Table S4 List of genome-wide significant associated SNPs and
ongoing replication attempts gathered.
(XLSX)
Table S5 Main features of gathered replication attempts.
(XLSX)
Table S6 Replicability per disease in Europeans. A) Using all
replication attempts and B) Using only replication attempts with
$80%.
(XLSX)
Table S7 Replicability per disease in East Asians. A) Using all
replication attempts and B) Using only replication attempts with
$80%.
(XLSX)
Table S8 List of potentially unreported replication attempts for
each East Asian GWAS.
(XLSX)
Table S9 Differences in LD among replicated and non-
replicated SNPs in 50-SNP consecutive windows.
(XLSX)
Table S10 Literature survey looking for candidate-based
replication attempts of variants discovered through GWAS. The
total number of PubMed and Google Scholar citations considered
for each of the disease-associated SNPs along with their discovery
GWAS is indicated. In total, up to six conditions were considered
in-depth: Alzheimer’s disease, osteoarthritis, non-Hodgkin lym-
phoma, narcolepsy, psoriasis and rheumatoid arthritis. The main
features about the candidate-based studies selected from the
selected citations are also indicated.
(XLSX)
Table S11 Main features of gathered replication attempts,
including candidate-based attempts, for the 6 analyzed diseases.
(XLSX)
Acknowledgments
We acknowledge colleagues from Navarro’s lab for technical support and
helpful comments. We also thank Greg Gibson, Peter M. Visscher, Isabel
Mendizabal, Rui Faria, Diego A. Hartasa´nchez, and Juan A. Rodrı´guez for
valuable discussion and smart insight.
Author Contributions
Analyzed the data: UMM. Wrote the paper: UMM AN. Conceived and
designed the study: UMM AN.
References
1. Visscher PM, Brown MA, McCarthy MI, Yang J (2012) Five years of GWAS
discovery. American journal of human genetics 90: 7–24.
2. Hindorff LA, Sethupathy P, Junkins HA, Ramos EM, Mehta JP, et al. (2009)
Potential etiologic and functional implications of genome-wide association loci
GWAS Variants Are Common and Shared across Eurasia
PLOS Genetics | www.plosgenetics.org 12 June 2013 | Volume 9 | Issue 6 | e1003566
for human diseases and traits. Proceedings of the National Academy of Sciences
of the United States of America 106: 9362–9367.
3. Eichler EE, Flint J, Gibson G, Kong A, Leal SM, et al. (2010) Missing
heritability and strategies for finding the underlying causes of complex disease.
Nature reviews 11: 446–450.
4. Gibson G (2012) Rare and common variants: twenty arguments. Nature
Reviews Genetics 13: 135–145.
5. Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, et al. (2009)
Finding the missing heritability of complex diseases. Nature 461: 747–753.
6. Yang J, Benyamin B, McEvoy BP, Gordon S, Henders AK, et al. (2010)
Common SNPs explain a large proportion of the heritability for human height.
Nature genetics 42: 565–569.
7. Anderson CA, Soranzo N, Zeggini E, Barrett JC (2011) Synthetic associations
are unlikely to account for many common disease genome-wide association
signals. PLoS biology 9: e1000580.
8. Dickson SP, Wang K, Krantz I, Hakonarson H, Goldstein DB (2010) Rare
variants create synthetic genome-wide associations. PLoS biology 8: e1000294.
9. Orozco G, Barrett JC, Zeggini E (2010) Synthetic associations in the context of
genome-wide association scan signals. Human molecular genetics 19: R137–144.
10. Wray NR, Purcell SM, Visscher PM (2011) Synthetic associations created by
rare variants do not explain most GWAS results. PLoS biology 9: e1000579.
11. Adeyemo A, Rotimi C (2009) Genetic variants associated with complex human
diseases show wide variation across multiple populations. Public Health
Genomics 13: 72–79.
12. Bustamante CD, Burchard EG, De la Vega FM (2011) Genomics for the world.
Nature 475: 163–165.
13. Ioannidis JP (2009) Population-wide generalizability of genome-wide discovered
associations. J Natl Cancer Inst 101: 1297–1299.
14. Marigorta UM, Lao O, Casals F, Calafell F, Morcillo-Suarez C, et al. (2011)
Recent human evolution has shaped geographical differences in susceptibility to
disease. BMC Genomics 12: 55.
15. Rosenberg NA, Huang L, Jewett EM, Szpiech ZA, Jankovic I, et al. (2010)
Genome-wide association studies in diverse populations. Nature reviews 11:
356–366.
16. Park JH, Gail MH, Weinberg CR, Carroll RJ, Chung CC, et al. (2011)
Distribution of allele frequencies and effect sizes and their interrelationships for
common genetic susceptibility variants. Proceedings of the National Academy of
Sciences of the United States of America 108: 18026–18031.
17. Waters KM, Stram DO, Hassanein MT, Le Marchand L, Wilkens LR, et al.
(2010) Consistent association of type 2 diabetes risk variants found in europeans
in diverse racial and ethnic groups. PLoS genetics 6: e1001078.
18. Durbin RM, Abecasis GR, Altshuler DL, Auton A, Brooks LD, et al. (2010) A
map of human genome variation from population-scale sequencing. Nature 467:
1061–1073.
19. Waters KM, Le Marchand L, Kolonel LN, Monroe KR, Stram DO, et al.
(2009) Generalizability of associations from prostate cancer genome-wide
association studies in multiple populations. Cancer Epidemiol Biomarkers Prev
18: 1285–1289.
20. Mathieson I, McVean G (2012) Differential confounding of rare and common
variants in spatially structured populations. Nature genetics 44: 243–246.
21. Fu J, Festen EA, Wijmenga C (2011) Multi-ethnic studies in complex traits.
Human molecular genetics 20: R206–213.
22. Ntzani EE, Liberopoulos G, Manolio TA, Ioannidis JP (2012) Consistency of
genome-wide associations across major ancestral groups. Human genetics 131:
1057–1071.
23. Hindorff LA, MacArthur J, (European Bioinformatics Institute), Wise A, Junkins
HA, Hall PN, et al. A atalog of Published Genome-Wide Association Studies.
Available: www.genome.gov/gwastudies.
24. McCarthy MI, Abecasis GR, Cardon LR, Goldstein DB, Little J, et al. (2008)
Genome-wide association studies for complex traits: consensus, uncertainty and
challenges. Nature reviews 9: 356–369.
25. N’Diaye A, Chen GK, Palmer CD, Ge B, Tayo B, et al. (2011) Identification,
replication, and fine-mapping of Loci associated with adult height in individuals
of african ancestry. PLoS genetics 7: e1002298.
26. Gravel S, Henn BM, Gutenkunst RN, Indap AR, Marth GT, et al. (2011)
Demographic history and rare allele sharing among human populations.
Proceedings of the National Academy of Sciences of the United States of
America 108: 11983–11988.
27. Keinan A, Clark AG (2012) Recent explosive human population growth has
resulted in an excess of rare genetic variants. Science 336: 740–743.
28. Nelson MR, Wegmann D, Ehm MG, Kessner D, St Jean P, et al. (2012) An
abundance of rare functional variants in 202 drug target genes sequenced in
14,002 people. Science 337: 100–104.
29. Barsh GS, Copenhaver GP, Gibson G, Williams SM (2012) Guidelines for
genome-wide association studies. PLoS genetics 8: e1002812.
30. Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN (2003) Meta-
analysis of genetic association studies supports a contribution of common
variants to susceptibility to common disease. Nature genetics 33: 177–182.
31. Ong RT, Teo YY (2010) varLD: a program for quantifying variation in linkage
disequilibrium patterns between populations. Bioinformatics 26: 1269–1270.
32. Han B, Eskin E (2012) Interpreting meta-analyses of genome-wide association
studies. PLoS genetics 8: e1002555.
33. Cho YS, Chen CH, Hu C, Long J, Ong RT, et al. (2012) Meta-analysis of
genome-wide association studies identifies eight new loci for type 2 diabetes in
east Asians. Nature genetics 44: 67–72.
34. Sullivan PF, Daly MJ, O’Donovan M (2012) Genetic architectures of psychiatric
disorders: the emerging picture and its implications. Nature reviews 13: 537–
551.
35. Park JH, Wacholder S, Gail MH, Peters U, Jacobs KB, et al. (2010) Estimation
of effect size distribution from genome-wide association studies and implications
for future discoveries. Nature genetics 42: 570–575.
36. Saxena R, Elbers CC, Guo Y, Peter I, Gaunt TR, et al. (2012) Large-scale gene-
centric meta-analysis across 39 studies identifies type 2 diabetes loci. American
journal of human genetics 90: 410–425.
37. Twee-Hee Ong R, Wang X, Liu X, Teo YY (2012) Efficiency of trans-ethnic
genome-wide meta-analysis and fine-mapping. Eur J Hum Genet 20: 1300–7.
38. Zaitlen N, Pasaniuc B, Gur T, Ziv E, Halperin E (2010) Leveraging genetic
variability across populations for the identification of causal variants. American
journal of human genetics 86: 23–33.
39. Yang J, Manolio TA, Pasquale LR, Boerwinkle E, Caporaso N, et al. (2011)
Genome partitioning of genetic variation for complex traits using common
SNPs. Nature genetics 43: 519–525.
40. Zuk O, Hechter E, Sunyaev HR, Lander ES (2012) The mystery of missing
heritability: Genetic interactions create phantom heritability. PNAS 109: 1193–
1198.
41. Yu W, Gwinn M, Clyne M, Yesupriya A, Khoury MJ (2008) A navigator for
human genome epidemiology. Nature genetics 40: 124–125.
42. Skol AD, Scott LJ, Abecasis GR, Boehnke M (2006) Joint analysis is more
efficient than replication-based analysis for two-stage genome-wide association
studies. Nature genetics 38: 209–213.
GWAS Variants Are Common and Shared across Eurasia
PLOS Genetics | www.plosgenetics.org 13 June 2013 | Volume 9 | Issue 6 | e1003566
